Literature DB >> 2189516

Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.

A S Malin1, A P Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189516      PMCID: PMC1662952          DOI: 10.1136/bmj.300.6733.1175

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Acute psychosis after mefloquine.

Authors:  P C Stuiver; R J Ligthelm; T J Goud
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

2.  RI quinine-Fansidar resistant falciparum malaria from Malawi.

Authors:  D C Warhurst; A P Hall; S Tjokrosonto
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

3.  Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.

Authors:  A P Hall; E B Doberstyn; V Mettaprakong; P Sonkom
Journal:  Br Med J       Date:  1975-04-05

4.  Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.

Authors:  A P Hall; E B Doberstyn; C Karnchanachetanee; S Samransamruajkit; B Laixuthai; E J Pearlman; R M Lampe; C F Miller; P Phintuyothin
Journal:  Br Med J       Date:  1977-06-25
  4 in total
  3 in total

Review 1.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

2.  Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia.

Authors:  A Björkman; M Willcox; N Marbiah; D Payne
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 3.  Drug resistance in malaria: a review of the west African situation.

Authors:  K O Adubofour
Journal:  J Natl Med Assoc       Date:  1992-12       Impact factor: 1.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.